|
Characteristics
|
No. of patients (%)
|
|---|
|
Age (years)
|
|
Median
|
47
|
|
Range
|
25–84
|
|
Stage (AJCC)
|
|
I/II
|
188 (50)
|
|
III/IV
|
188 (50)
|
|
Histological grade
|
|
1
|
108 (29)
|
|
2
|
179 (48)
|
|
3
|
89 (23)
|
|
Missing
|
0 (0)
|
|
ER
|
|
Negative
|
169 (45)
|
|
Positive
|
207 (55)
|
|
Missing
|
0 (0)
|
|
PR
|
|
Negative
|
124 (33)
|
|
Positive
|
252 (67)
|
|
Missing
|
0 (0)
|
|
HER2
|
|
Negative
|
211 (56)
|
|
Positive
|
165 (44)
|
|
Missing
|
0
|
|
Luminal
|
288 (77)
|
|
HER-2 subtypes
|
53 (14)
|
|
TNBC
|
35 (9)
|
|
Ki-67
|
|
Low expressiona
|
281 (75)
|
|
High expressionb
|
88 (23)
|
|
Missing
|
7 (2)
|
|
Mutational P53
|
|
Low expressiona
|
196 (52)
|
|
High expressionb
|
165 (44)
|
|
Missing
|
15 (4)
|
|
VEGF
|
|
Low expressiona
|
302 (80)
|
|
High expressionb
|
64 (17)
|
|
Missing
|
10 (3)
|
|
Radiotherapy
|
|
Yes
|
91 (24)
|
|
No
|
285 (76)
|
|
Chemotherapy
|
|
Yes
|
367 (98)
|
|
No
|
9 (2)
|
- aLow expression represented -, +, ++ staining index in IHC examination
- bHigh expression represented +++, ++++ staining index in IHC examination
